ABCL vs. ABSI
ABCL (AbCellera Biologics Inc.) and ABSI (Absci Corporation) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, ABCL returned -17.75%/yr vs -22.86%/yr for ABSI. Their 0.48 correlation means their historical movements had little consistent relationship.
Performance
ABCL vs. ABSI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ABCL achieves a 66.96% return, which is significantly lower than ABSI's 122.92% return.
ABCL
- 1D
- 0.35%
- 1M
- -29.59%
- 6M
- 57.73%
- YTD
- 66.96%
- 1Y
- 34.67%
- 3Y*
- -7.74%
- 5Y*
- -17.75%
- 10Y*
- —
- ALL TIME*
- -34.32%
ABSI
- 1D
- 1.83%
- 1M
- -33.05%
- 6M
- 160.20%
- YTD
- 122.92%
- 1Y
- 168.28%
- 3Y*
- 56.24%
- 5Y*
- -22.86%
- 10Y*
- —
- ALL TIME*
- -17.93%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $27.22M | $36.48M | $44.45M | |
| $21.31M | $35.90M | $45.15M |
ABCL vs. ABSI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ABCL AbCellera Biologics Inc. | 66.96% | 16.72% | -48.69% | -43.63% | -29.16% | -13.96% |
ABSI Absci Corporation | 122.92% | 33.21% | -37.62% | 100.00% | -74.39% | -60.95% |
Correlation
The correlation between ABCL and ABSI is 0.63, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.63 |
Correlation (3Y) Balances recent behavior with more history. | 0.54 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.49 |
Correlation (All Time) Calculated using the full available price history since Jul 22, 2021 | 0.48 |
The correlation between ABCL and ABSI shifts across timeframes, from 0.48 (all time) to 0.63 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
ABCL:
$1.74B
ABSI:
$1.32B
ABCL:
-$0.48
ABSI:
-$0.79
ABCL:
21.64
ABSI:
715.67
ABCL:
1.84
ABSI:
6.92
ABCL:
$79.21M
ABSI:
$1.62M
ABCL:
$70.89M
ABSI:
-$21.67M
ABCL:
-$166.07M
ABSI:
-$115.23M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABCL vs. ABSI — Risk / Return Rank
ABCL
ABSI
ABCL vs. ABSI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AbCellera Biologics Inc. (ABCL) and Absci Corporation (ABSI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ABCL | ABSI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.33 | ||
| Sortino ratioReturn per unit of downside risk | -1.53 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.31 | -0.18 |
| Calmar ratioReturn relative to maximum drawdown | 0.51 | 3.26 | -2.75 |
| Martin ratioReturn relative to average drawdown | 0.91 | 6.14 | -5.23 |
Loading charts...
Drawdowns
ABCL vs. ABSI - Drawdown Comparison
The maximum ABCL drawdown since its inception was -96.84%, roughly equal to the maximum ABSI drawdown of -96.20%. Use the drawdown chart below to compare losses from any high point for ABCL and ABSI.
Loading charts...
Drawdown Indicators
| ABCL | ABSI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.84% | -96.20% | -0.64% |
Max Drawdown (1Y)Largest decline over 1 year | -54.94% | -54.00% | -0.94% |
Max Drawdown (3Y)Largest decline over 3 years | -68.05% | -66.06% | -1.99% |
Max Drawdown (5Y)Largest decline over 5 years | -90.96% | -95.83% | +4.87% |
Current DrawdownCurrent decline from peak | -90.64% | -74.31% | -16.33% |
Average DrawdownAverage peak-to-trough decline | -84.26% | -84.31% | +0.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.52% | 28.60% | +1.92% |
Volatility
ABCL vs. ABSI - Volatility Comparison
The current volatility for AbCellera Biologics Inc. (ABCL) is 22.72%, while Absci Corporation (ABSI) has a volatility of 24.57%. This indicates that ABCL experiences smaller price fluctuations and is considered to be less risky than ABSI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ABCL | ABSI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.72% | 24.57% | -1.85% |
Volatility (6M)Calculated over the trailing 6-month period | 58.57% | 76.53% | -17.96% |
Volatility (1Y)Calculated over the trailing 1-year period | 77.27% | 104.44% | -27.17% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 67.67% | 98.15% | -30.48% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 70.72% | 98.23% | -27.51% |
Dividends
ABCL vs. ABSI - Dividend Comparison
Neither ABCL nor ABSI has paid dividends to shareholders.
Financials
ABCL vs. ABSI - Financials Comparison
This section allows you to compare key financial metrics between AbCellera Biologics Inc. and Absci Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ABCL and ABSI have a correlation of 0.63, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ABSI has higher volatility (24.57%) compared to ABCL (22.72%). In terms of maximum drawdown, ABCL dropped -96.84% vs ABSI's -96.20%.
ABSI currently has the higher Sharpe Ratio (1.69 vs 0.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ABCL and ABSI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer